Table 3.
Average quality of life (index and VAS) for the 12-week period according to type of intervention and analysis (intention to treat and per protocol).
| Quality of Life | Baseline | Average Over Intervention | p Value a | |||
|---|---|---|---|---|---|---|
| ONS + DA | DA | |||||
| Intention to treat analysis | ||||||
| n = 154 | n = 154 | |||||
| EQ-5D-5L index | 0.735 | 0.753 | 0.011 | 0.743 | 0.010 | 0.425 |
| ED-5D-5L VAS | 65.0 | 67.6 | 1.1 | 66.2 | 1.3 | 0.344 |
| Per protocol analysis | ||||||
| n = 126 | n = 104 | |||||
| EQ-5D-5L index | 0.735 | 0.783 | 0.009 | 0.780 | 0.010 | 0.815 |
| ED-5D-5L VAS | 66.8 | 69.8 | 1.0 | 70.6 | 1.1 | 0.582 |
ONS, oral nutritional supplement. DA, dietary advice. EQ5D, Euroqol. VAS, visual analogue scale; a Univariate analysis adjusted for the baseline EQ-5D, MUST category, CCI, age and gender; Data presented as mean ± SE.